Synergistic effects of achieving perinatal interventions on bronchopulmonary dysplasia in preterm infants
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
To investigate the effect of perinatal interventions on the risk of severe BPD (sBPD) and death in extremely preterm infants (EPIs) and their synergistic effects. This was a secondary analysis of the prospective cohort Chinese Neonatal Network (CHNN). Infants with a birth weight of 500 to 1250 g or 24-28 weeks completed gestational age were recruited. The impacts and the synergistic effects of six evidence-based perinatal interventions on the primary outcomes of sBPD and death were assessed by univariate and multivariable logistic regression modeling. Totally, 6568 EPIs were finally enrolled. Antenatal corticosteroid (adjusted OR, aOR, 0.74; 95%CI, 0.65-083), birth in centers with tertiary NICU (aOR, 0.64; 95%CI, 0.57-0.72), preventing intubation in the delivery room (aOR, 0.65; 95%CI, 0.58-0.73), early caffeine therapy (aOR, 0.59; 95%CI, 0.52-0.66), and early extubating (aOR, 0.42; 95%CI 0.37-0.47), were strongly associated with a lower risk of sBPD and death while early surfactant administration was associated with a lower risk of death (aOR, 0.84; 95%CI, 0.72, 0.98). Compared with achieving 0/1 perinatal interventions, achieving more than one intervention was associated with decreased rates (46.6% in 0/1 groups while 38.5%, 29.6%, 22.2%, 16.2%, and 11.7% in 2/3/4/5/6-intervention groups respectively) and reduced risks of sBPD/death with aORs of 0.76(0.60, 0.96), 0.55(0.43, 0.69), 0.38(0.30, 0.48), 0.28(0.22, 0.36), and 0.20(0.15, 0.27) in 2, 3, 4, 5, and 6 intervention groups respectively. Subgroup analyses showed consistent results.
CONCLUSION: Six perinatal interventions can effectively reduce the risk of sBPD and death in a synergistic form.
WHAT IS KNOWN: • Bronchopulmonary dysplasia (BPD) is a multifactorial chronic lung disease associated with prematurity. The effective management of BPD requires a comprehensive set of interventions. However, the extent to which these interventions can mitigate the risk of severe outcomes, such as severe BPD or mortality, or if they possess synergistic effects remains unknown.
WHAT IS NEW: • The implementation of various perinatal interventions, such as prenatal steroids, birth in centers with tertiary NICU, early non-Invasive respiratory support, surfactant administration within 2 hours after birth, early caffeine initiation within 3 days, and early extubation within 7 days after birth has shown promising results in the prevention of severe bronchopulmonary dysplasia (BPD) or mortality in extremely preterm infants. Moreover, these interventions have demonstrated synergistic effects when implemented in combination.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:183 |
---|---|
Enthalten in: |
European journal of pediatrics - 183(2024), 4 vom: 22. Apr., Seite 1711-1721 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Xiang [VerfasserIn] |
---|
Links: |
---|
Themen: |
3G6A5W338E |
---|
Anmerkungen: |
Date Completed 09.04.2024 Date Revised 09.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00431-023-05355-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367217996 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367217996 | ||
003 | DE-627 | ||
005 | 20240409232337.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240117s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00431-023-05355-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1370.xml |
035 | |a (DE-627)NLM367217996 | ||
035 | |a (NLM)38231237 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Xiang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synergistic effects of achieving perinatal interventions on bronchopulmonary dysplasia in preterm infants |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.04.2024 | ||
500 | |a Date Revised 09.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
520 | |a To investigate the effect of perinatal interventions on the risk of severe BPD (sBPD) and death in extremely preterm infants (EPIs) and their synergistic effects. This was a secondary analysis of the prospective cohort Chinese Neonatal Network (CHNN). Infants with a birth weight of 500 to 1250 g or 24-28 weeks completed gestational age were recruited. The impacts and the synergistic effects of six evidence-based perinatal interventions on the primary outcomes of sBPD and death were assessed by univariate and multivariable logistic regression modeling. Totally, 6568 EPIs were finally enrolled. Antenatal corticosteroid (adjusted OR, aOR, 0.74; 95%CI, 0.65-083), birth in centers with tertiary NICU (aOR, 0.64; 95%CI, 0.57-0.72), preventing intubation in the delivery room (aOR, 0.65; 95%CI, 0.58-0.73), early caffeine therapy (aOR, 0.59; 95%CI, 0.52-0.66), and early extubating (aOR, 0.42; 95%CI 0.37-0.47), were strongly associated with a lower risk of sBPD and death while early surfactant administration was associated with a lower risk of death (aOR, 0.84; 95%CI, 0.72, 0.98). Compared with achieving 0/1 perinatal interventions, achieving more than one intervention was associated with decreased rates (46.6% in 0/1 groups while 38.5%, 29.6%, 22.2%, 16.2%, and 11.7% in 2/3/4/5/6-intervention groups respectively) and reduced risks of sBPD/death with aORs of 0.76(0.60, 0.96), 0.55(0.43, 0.69), 0.38(0.30, 0.48), 0.28(0.22, 0.36), and 0.20(0.15, 0.27) in 2, 3, 4, 5, and 6 intervention groups respectively. Subgroup analyses showed consistent results | ||
520 | |a CONCLUSION: Six perinatal interventions can effectively reduce the risk of sBPD and death in a synergistic form | ||
520 | |a WHAT IS KNOWN: • Bronchopulmonary dysplasia (BPD) is a multifactorial chronic lung disease associated with prematurity. The effective management of BPD requires a comprehensive set of interventions. However, the extent to which these interventions can mitigate the risk of severe outcomes, such as severe BPD or mortality, or if they possess synergistic effects remains unknown | ||
520 | |a WHAT IS NEW: • The implementation of various perinatal interventions, such as prenatal steroids, birth in centers with tertiary NICU, early non-Invasive respiratory support, surfactant administration within 2 hours after birth, early caffeine initiation within 3 days, and early extubation within 7 days after birth has shown promising results in the prevention of severe bronchopulmonary dysplasia (BPD) or mortality in extremely preterm infants. Moreover, these interventions have demonstrated synergistic effects when implemented in combination | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Bronchopulmonary dysplasia | |
650 | 4 | |a Extremely preterm infants | |
650 | 4 | |a Perinatal interventions | |
650 | 4 | |a Synergistic effects | |
650 | 7 | |a Caffeine |2 NLM | |
650 | 7 | |a 3G6A5W338E |2 NLM | |
650 | 7 | |a Pulmonary Surfactants |2 NLM | |
650 | 7 | |a Surface-Active Agents |2 NLM | |
700 | 1 | |a Yuan, Lin |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Siyuan |e verfasserin |4 aut | |
700 | 1 | |a Gu, Xinyue |e verfasserin |4 aut | |
700 | 1 | |a Lei, Xiaoping |e verfasserin |4 aut | |
700 | 1 | |a Hu, Liyuan |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Tiantian |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Yanping |e verfasserin |4 aut | |
700 | 1 | |a Dang, Dan |e verfasserin |4 aut | |
700 | 1 | |a Li, Wenli |e verfasserin |4 aut | |
700 | 1 | |a Cao, Yun |e verfasserin |4 aut | |
700 | 1 | |a Du, Lizhong |e verfasserin |4 aut | |
700 | 1 | |a Lee, Shoo K |e verfasserin |4 aut | |
700 | 1 | |a Chen, Chao |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Wenhao |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Jianguo |e verfasserin |4 aut | |
700 | 0 | |a Chinese Neonatal Network |e verfasserin |4 aut | |
700 | 1 | |a Lu, Yulan |e investigator |4 oth | |
700 | 1 | |a Yang, Tongling |e investigator |4 oth | |
700 | 1 | |a Yang, Jie |e investigator |4 oth | |
700 | 1 | |a Yuan, Hao |e investigator |4 oth | |
700 | 1 | |a Wang, Li |e investigator |4 oth | |
700 | 1 | |a Yuan, Lin |e investigator |4 oth | |
700 | 1 | |a Lee, Shoo K |e investigator |4 oth | |
700 | 1 | |a Chen, Chao |e investigator |4 oth | |
700 | 1 | |a Du, Lizhong |e investigator |4 oth | |
700 | 1 | |a Zhou, Wenhao |e investigator |4 oth | |
700 | 1 | |a Cao, Yun |e investigator |4 oth | |
700 | 1 | |a Cheng, Xiuyong |e investigator |4 oth | |
700 | 1 | |a Zhang, Huayan |e investigator |4 oth | |
700 | 1 | |a Tian, Xiuying |e investigator |4 oth | |
700 | 1 | |a Shi, Jingyun |e investigator |4 oth | |
700 | 1 | |a Li, Zhankui |e investigator |4 oth | |
700 | 1 | |a Yang, Chuanzhong |e investigator |4 oth | |
700 | 1 | |a Liu, Ling |e investigator |4 oth | |
700 | 1 | |a Yang, Zuming |e investigator |4 oth | |
700 | 1 | |a Fu, Jianhua |e investigator |4 oth | |
700 | 1 | |a Ji, Yong |e investigator |4 oth | |
700 | 1 | |a Chen, Dongmei |e investigator |4 oth | |
700 | 1 | |a Yang, Changyi |e investigator |4 oth | |
700 | 1 | |a Chen, Rui |e investigator |4 oth | |
700 | 1 | |a Peng, Xiaoming |e investigator |4 oth | |
700 | 1 | |a Shan, Ruobing |e investigator |4 oth | |
700 | 1 | |a Han, Shuping |e investigator |4 oth | |
700 | 1 | |a Wu, Hui |e investigator |4 oth | |
700 | 1 | |a Wang, Lili |e investigator |4 oth | |
700 | 1 | |a Wei, Qiufen |e investigator |4 oth | |
700 | 1 | |a Li, Mingxia |e investigator |4 oth | |
700 | 1 | |a Dai, Yiheng |e investigator |4 oth | |
700 | 1 | |a Jiang, Hong |e investigator |4 oth | |
700 | 1 | |a Kang, Wenqing |e investigator |4 oth | |
700 | 1 | |a Gong, Xiaohui |e investigator |4 oth | |
700 | 1 | |a Zhong, Xiaoyun |e investigator |4 oth | |
700 | 1 | |a Shi, Yuan |e investigator |4 oth | |
700 | 1 | |a Jiang, Shanyu |e investigator |4 oth | |
700 | 1 | |a Sun, Bin |e investigator |4 oth | |
700 | 1 | |a Li, Long |e investigator |4 oth | |
700 | 1 | |a Lin, Zhenlang |e investigator |4 oth | |
700 | 1 | |a Liu, Jiangqin |e investigator |4 oth | |
700 | 1 | |a Pan, Jiahua |e investigator |4 oth | |
700 | 1 | |a Xia, Hongping |e investigator |4 oth | |
700 | 1 | |a Li, Xiaoying |e investigator |4 oth | |
700 | 1 | |a Xu, Falin |e investigator |4 oth | |
700 | 1 | |a Qiu, Yinping |e investigator |4 oth | |
700 | 1 | |a Ma, Li |e investigator |4 oth | |
700 | 1 | |a Yang, Ling |e investigator |4 oth | |
700 | 1 | |a He, Xiaori |e investigator |4 oth | |
700 | 1 | |a Li, Yanhong |e investigator |4 oth | |
700 | 1 | |a Zhuang, Deyi |e investigator |4 oth | |
700 | 1 | |a Zhang, Qin |e investigator |4 oth | |
700 | 1 | |a Dong, Wenbin |e investigator |4 oth | |
700 | 1 | |a Sun, Jianhua |e investigator |4 oth | |
700 | 1 | |a Liang, Kun |e investigator |4 oth | |
700 | 1 | |a Wang, Huaiyan |e investigator |4 oth | |
700 | 1 | |a Feng, Jinxing |e investigator |4 oth | |
700 | 1 | |a Lin, Xinzhu |e investigator |4 oth | |
700 | 1 | |a Jiang, Chunming |e investigator |4 oth | |
700 | 1 | |a Nie, Chuan |e investigator |4 oth | |
700 | 1 | |a Zeng, Lingkong |e investigator |4 oth | |
700 | 1 | |a Hei, Mingyan |e investigator |4 oth | |
700 | 1 | |a Zhu, Hongdan |e investigator |4 oth | |
700 | 1 | |a Mi, Hongying |e investigator |4 oth | |
700 | 1 | |a Yin, Zhaoqing |e investigator |4 oth | |
700 | 1 | |a Song, Hongxia |e investigator |4 oth | |
700 | 1 | |a Wang, Hongyun |e investigator |4 oth | |
700 | 1 | |a Wang, Jinyuan |e investigator |4 oth | |
700 | 1 | |a Gao, Yan |e investigator |4 oth | |
700 | 1 | |a Wang, Yajuan |e investigator |4 oth | |
700 | 1 | |a Dai, Liying |e investigator |4 oth | |
700 | 1 | |a Zhang, Liyan |e investigator |4 oth | |
700 | 1 | |a Li, Yangfang |e investigator |4 oth | |
700 | 1 | |a Zhang, Qianshen |e investigator |4 oth | |
700 | 1 | |a Ding, Guofang |e investigator |4 oth | |
700 | 1 | |a Wang, Jimei |e investigator |4 oth | |
700 | 1 | |a Chen, Xiaoxia |e investigator |4 oth | |
700 | 1 | |a Wang, Zhen |e investigator |4 oth | |
700 | 1 | |a Tang, Zheng |e investigator |4 oth | |
700 | 1 | |a Ma, Xiaolu |e investigator |4 oth | |
700 | 1 | |a Zhang, Xiaomei |e investigator |4 oth | |
700 | 1 | |a Zhang, Xiaolan |e investigator |4 oth | |
700 | 1 | |a Wu, Fang |e investigator |4 oth | |
700 | 1 | |a Chen, Yanxiang |e investigator |4 oth | |
700 | 1 | |a Wu, Ying |e investigator |4 oth | |
700 | 1 | |a Ting, Joseph |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t European journal of pediatrics |d 1978 |g 183(2024), 4 vom: 22. Apr., Seite 1711-1721 |w (DE-627)NLM000029718 |x 1432-1076 |7 nnns |
773 | 1 | 8 | |g volume:183 |g year:2024 |g number:4 |g day:22 |g month:04 |g pages:1711-1721 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00431-023-05355-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 183 |j 2024 |e 4 |b 22 |c 04 |h 1711-1721 |